Vitara Biomedical

Philadelphia, United States

Vitara Biomedical develops a therapeutic platform to support premature infants.

$50.0M raised

Nov 2024

Series B

Child Care Health Care Health Diagnostics Medical Device

Top Investors

Khosla VenturesSands Capital VenturesFirst Spark VenturesGoogle VenturesThe Children's Hospital of Philadelphia

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vitara Biomedical

How much funding has Vitara Biomedical raised?

Vitara Biomedical has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in November 2024.

Who are Vitara Biomedical's investors?

Vitara Biomedical's investors include Khosla Ventures, Sands Capital Ventures, First Spark Ventures, Google Ventures, The Children's Hospital of Philadelphia.

Where is Vitara Biomedical headquartered?

Vitara Biomedical is headquartered in Philadelphia, United States.

What does Vitara Biomedical do?

Vitara Biomedical develops a therapeutic platform to support premature infants.

What stage is Vitara Biomedical at?

Vitara Biomedical is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 18, 2024.

MLA

"Vitara Biomedical — Funding & Investors." VCBacked, November 18, 2024, https://www.vcbacked.co/company/vitara-biomedical. Accessed June 3, 2026.

APA

VCBacked. (2024). Vitara Biomedical — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/vitara-biomedical

Wikipedia (cite web)

{{cite web |title=Vitara Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/vitara-biomedical |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 18, 2024.